Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $34.5700 (1.53%) ($33.0500 - $34.9200) on Thu. Jan. 10, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.17% (three month average) | RSI | 44 | Latest Price | $34.5700(1.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -0.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(50%) IWO(49%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.585% in a week (0% probabilities). VXX(-14%) TLT(-13%) VIXM(-12%) UUP(-12%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.585% (StdDev 5.17%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
1 - 5 Day Possible Target | $13.82(-60.02%) | Resistance Level | $35.13 | 5 Day Moving Average | $33.1(4.44%) | 10 Day Moving Average | $33.26(3.94%) | 20 Day Moving Average | $35.13(-1.59%) | To recent high | -19.5% | To recent low | 21.7% | Market Cap | $2.569b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |